XML 14 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjusted Balance
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2022     876 1,407        
Beginning balance at Dec. 31, 2022 $ (477) $ (2) $ 0 $ 1 $ 148,545 $ (3) $ (149,020) $ (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common (in shares)       285        
Issuance of common stock 3,025     $ 1 3,024      
Stock issued in exchange transactions (in shares)       1,057        
Stock issued in exchange transactions 1,716       1,716      
Stock-based compensation 26       26      
Net loss (1,333)           (1,333)  
Ending balance (in shares) at Mar. 31, 2023     876 2,749        
Ending balance at Mar. 31, 2023 2,955   $ 0 $ 2 153,311 (3) (150,355)  
Beginning balance (in shares) at Dec. 31, 2022     876 1,407        
Beginning balance at Dec. 31, 2022 (477) (2) $ 0 $ 1 148,545 (3) (149,020) (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (3,444)              
Ending balance (in shares) at Sep. 30, 2023     876 4,349        
Ending balance at Sep. 30, 2023 3,892   $ 0 $ 0 156,361 (3) (152,466)  
Beginning balance (in shares) at Dec. 31, 2022     876 1,407        
Beginning balance at Dec. 31, 2022 (477) $ (2) $ 0 $ 1 148,545 (3) (149,020) $ (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (4,300)              
Ending balance (in shares) at Dec. 31, 2023     876 4,349        
Ending balance at Dec. 31, 2023 3,051   $ 0 $ 0 156,369 (3) (153,315)  
Beginning balance (in shares) at Mar. 31, 2023     876 2,749        
Beginning balance at Mar. 31, 2023 2,955   $ 0 $ 2 153,311 (3) (150,355)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common (in shares)       747        
Issuance of common stock 1,304       1,304      
Par value adjustment due to reverse stock split 0     $ (2) 2      
Reduction in equity due to costs from reverse stock split (16)       (16)      
Stock-based compensation 23       23      
Net loss (1,167)           (1,167)  
Ending balance (in shares) at Jun. 30, 2023     876 3,496        
Ending balance at Jun. 30, 2023 3,099   $ 0 $ 0 154,624 (3) (151,522)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock and warrants (in shares)       853        
Issuance of common stock and warrants 1,750       1,750      
Stock-based compensation (13)       (13)      
Net loss (944)           (944)  
Ending balance (in shares) at Sep. 30, 2023     876 4,349        
Ending balance at Sep. 30, 2023 3,892   $ 0 $ 0 156,361 (3) (152,466)  
Beginning balance (in shares) at Dec. 31, 2023     876 4,349        
Beginning balance at Dec. 31, 2023 3,051   $ 0 $ 0 156,369 (3) (153,315)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common (in shares)       283        
Issuance of common stock 450     $ 0 450      
Conversion of advanced capital contribution to common stock (in shares)       94        
Conversion of advanced capital contribution to common stock 141       141      
Stock-based compensation 1       1      
Net loss (418)           (418)  
Ending balance (in shares) at Mar. 31, 2024     876 4,726        
Ending balance at Mar. 31, 2024 3,225   $ 0 $ 0 156,961 (3) (153,733)  
Beginning balance (in shares) at Dec. 31, 2023     876 4,349        
Beginning balance at Dec. 31, 2023 3,051   $ 0 $ 0 156,369 (3) (153,315)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (1,288)              
Ending balance (in shares) at Sep. 30, 2024     876 5,261        
Ending balance at Sep. 30, 2024 3,207   $ 0 $ 1 157,812 (3) (154,603)  
Beginning balance (in shares) at Mar. 31, 2024     876 4,726        
Beginning balance at Mar. 31, 2024 3,225   $ 0 $ 0 156,961 (3) (153,733)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common (in shares)       535        
Issuance of common stock 851     $ 1 850      
Net loss (554)           (554)  
Ending balance (in shares) at Jun. 30, 2024     876 5,261        
Ending balance at Jun. 30, 2024 3,522   $ 0 $ 1 157,811 (3) (154,287)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation 1       1      
Net loss (316)           (316)  
Ending balance (in shares) at Sep. 30, 2024     876 5,261        
Ending balance at Sep. 30, 2024 $ 3,207   $ 0 $ 1 $ 157,812 $ (3) $ (154,603)